Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BGIICC 2018 /
Immunotherapy and targeted treatments in breast cancer reviewed

18th - 19th Jan 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.01.18
Views: 1950

Dr Hesham El Ghazaly and Prof Leisha Emens

Dr Hesham El Ghazaly, Ain Shams University, Cairo, Egypt and Prof Leisha Emens, Johns Hopkins Kimmel Cancer, Baltimore, USA speak at the 10th BGICC in Cairo, discussing conference highlights.

They cover conference sessions on immunotherapeutics, considering the prospects for future regimens and the importance of therapy timing and combinations, and Prof Emens also details the micro-environment of breast cancer and potential targets.

In closing, they offer an invitation to next years conference, focussing on the mentoring available in dedicated sessions for young oncologists.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation